Moshe A. Milevsky is a leading authority on the intersection of wealth management, financial mathematics and insurance.
As a tenured professor in a business school he has one foot planted squarely in the ivory tower and the other in the commercial world, with a unique communication style and talent for explaining complex ideas clearly and with humor.
Speaking & Lectures
Learn about his public keynote presentations and availability for speaking engagements.
University & Research
Learn about his teaching and research at the Schulich School of Business, York University.
Books & Writing
Learn about popular books and scholarly articles he has recently published.
Consulting & Coaching
Prof. Milevsky has interests in a number of commercial ventures, which are explained and disclosed here.
Moshe A. Milevsky is a finance professor at the Schulich School of Business at York University in Toronto. He is also a member of the graduate faculty in the Department of Mathematics and Statistics and Managing Director of PiLECo.
Moshe A. Milevsky has published 15 books (translated into 6 languages) and over sixty peer-reviewed scholarly papers in addition to hundreds of popular articles and blog pieces. In addition to being an award-winning author, he is a fin-tech entrepreneur with a number of U.S. patents and computational innovations in the retirement income space. He was named by Investment Advisor magazine as one of the 35 most influential people in the U.S. financial advisory business during the last 35 years, and he received a lifetime achievement award from the Retirement Income Industry Association.
My day-job at the University revolves around teaching undergraduate, graduate and doctoral students, courses on wealth management, investments, insurance, pensions and retirement planning.
As part of my academic responsibilities, I publish books, popular articles and technical papers, many of which you can download or link-to from this website.
My current research interests revolve around the area of financial history and the evolution of (retirement) insurance & annuity products over the centuries.
Quiz question: How can median age at death during a pandemic be *higher* than normal times? Show your work.
Your life expectancy is extended by approximately the amount of time you spend in a "hyperbaric oxygen therapy chamber", so it's a bit of a wash... https://t.co/qmDtGmVPoY
Well, they certainly didn't ask me... https://t.co/M6S6q9fHzA
If the market drops today, you can “blame” it on this “news”. Otherwise, feel free to ignore. https://t.co/HDVU5CYm0f
Yes. I used to mention the Spanish Flu quite a bit in my lectures about longevity risk and insurance. Can’t do that anymore. People are sick of that flu... https://t.co/7vOghTx06S
You savor the title, admire the clever cover, read the two sentence description, and think “...but, an entire book?” https://t.co/Sc0FW7c10E
Oh, gees. I’m going to have to delete *so* much material from my retirement and pensions course. So sad. (About Chile, of course.) They were a beacon of rational annuity policy. https://t.co/mkukEOa9dk
Yea, I tend to agree. Not a big fan of RM’s. That drug has pernicious side effects. https://t.co/DATOVPEClj
The time-decay of an option is now a storm. https://t.co/G2XUJ1p4Nh
Stupid for which side of the transaction? https://t.co/Si27nkgAye
No mention of the interest rate... 🤔 https://t.co/kQQEzEKIH4
Sadducees won popular vote, but electoral college went to the Pharisees. https://t.co/thBJCYtrQ7
RT @ThatAnnuityShow: Most people go by their chronological age, however, Moshe Milevsky wants you to go by your biological age when it come…